NOVADIP
PrivateLast Round
Debt
Dec 14, 2023
Total Funding Raised
$96.54M
Company Overview
NOVADIP is a biotechnology company specializing in cell-based regeneration therapies that create innovative regenerative tissue products to enhance healing for large bone defects, bone non-union, and spine fusion in a single treatment.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NOVADIP Comps
Public and private peers based on sector, stage, and business model.
NOVADIP Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Dec 14, 2023 | ||||
| Series B Extension | Nov 3, 2022 | ||||
| Series B | Oct 28, 2021 | ||||
| Series A | Sep 10, 2015 |
Key People
Founding team and executive leadership
NOVADIP Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Fund+ | Series A, Series B, Series B Extension |
| Société Régionale d'Investissement de Wallonie | Series A |
| Investsud | Series B, Series B Extension |
| European Investment Bank Group | Debt |
| Nivelinvest | Series B, Series A |
| Financière Spin-off Luxembourgeoise | Series B |
| New Science Ventures | Series B, Series A, Series B Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 10, 2025
Added Altesia, a consulting startup, as a customer.
- Apr 15, 2025
Abbey joins as President and CEO, previously leading Argos Therapeutics.
NOVADIP Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about NOVADIP's valuation, stock price, and market status.
